Trump's 'Liberation Day' and a labor report: What to know this week

Image source: Adobe Stock

📆 Trump's 'Liberation Day' and a labor report: What to know this week: Stocks are hovering near their lowest levels of the year, with President Trump's latest tariff announcements and fears about the US economy's path forward sending equities lower in the final full week of the first quarter. Yahoo Finance reports.

🌐 Arm expects its share of data center CPU market sales to rocket to 50% this year: Arm Holdings expects its share of the global market for data center central processing units to surge to 50% by the end of the year, up from about 15% in 2024 with gains driven by the boom in artificial intelligence, a senior executive said. Yahoo Finance reports.

🍟 How McDonald’s and other fast-food restaurants offer protection from Trump tariffs: President Donald Trump is a big fan of fast food, and investors might become aficionados too as a way to ride out the impact of tariffs, according to a basket of stocks put together by Morgan Stanley. MarketWatch reports.

🏆 Gold rises above $3,100 for first time as US levies boost havens: Gold started the week with a fresh record high, ahead of President Donald Trump’s expected latest tariff barrage that’s heightened concerns of a global trade war. Yahoo Finance reports.

🏦 China's biggest state banks to raise $71.6 billion to boost capital: Four of China's largest state-owned banks said on Sunday they plan to raise a combined 520 billion yuan ($71.60 billion) in private placements from investors, including the finance ministry, after Beijing pledged to help them support the economy. Reuters reports.

📱 Huawei 2024 revenue surges to near-record high as China smartphone comeback takes hold: Huawei on Monday reported a sharp jump in 2024 revenue as its core telecommunications and consumer businesses accelerated. Huawei reported revenue for 2024 of 862.1 billion Chinese yuan ($118.2 billion), a 22.4% year-on-year rise. CNBC reports.

💊 Novo Nordisk’s diabetes pill slashes risk of cardiovascular complications by 14% after four years: Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with diabetes and heart disease. CNBC reports.

(All pricing and percent gains are based on Early Pre-Market from 4:00 AM to 7:00 AM Eastern Time)
Benzinga reports.

1) ICCT: iCoreConnect
Total gain: +111.24%

2) $CTOR: Citius Oncology
Total gain: +78.94%

3) $TGL: Treasure Global
Total gain: +48.12%

4) $QSG: QuantaSing Group
Total gain: +23.39%

5) $GRYP: Gryphon Digital Mining
Total gain: +21.43%

*Estimate and Actual numbers represent Earnings Per Share in US Dollars


MVST: Microvast Holdings
4Q 2024After Market Close
Estimate: 0.000
Actual: N/A

RCAT: Red Cat Holdings
3Q 2025After Market Close
Estimate: -0.090
Actual: N/A

CELC: Celcuity
4Q 2024After Market Close
Estimate: -0.670
Actual: N/A

Time (ET) / Report / Period

9:45 am - Chicago Business Barometer (PMI) - March

“In a narrow market, when prices are not getting anywhere to speak of but move within a narrow range, there is no sense in trying to anticipate what next big movement is going to be.”

- Edwin Lefèvre

Sourced in: “Reminiscences of a Stock Operator”, by Edwin Lefèvre, published in 1923